Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics
Language English Country Switzerland Media electronic
Document type Journal Article
Grant support
NU20-03-00309
Ministry of Health of the Czech Republic
CZ.1.05/1.1.00/02.0109
BIOCEV
86652036
Institute of Biotechnology RVO
20-09811Y
Czech Science Foundation
LQ200202002
Czech Academy of Sciences
19-08176S
Czech Science Foundation
PubMed
35008521
PubMed Central
PMC8744867
DOI
10.3390/ijms23010097
PII: ijms23010097
Knihovny.cz E-resources
- Keywords
- Enterococcus faecium, MD simulation, Staphylococcus aureus, antibiotic resistance, benzimidazole, docking, ligands, lipoglycopeptide antibiotic, teicoplanin VanZ,
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Drug Resistance, Bacterial drug effects MeSH
- Bacterial Proteins metabolism MeSH
- Gram-Positive Bacterial Infections drug therapy MeSH
- Gram-Positive Bacteria drug effects MeSH
- Humans MeSH
- Lipoglycopeptides pharmacology MeSH
- Microbial Sensitivity Tests methods MeSH
- Molecular Docking Simulation methods MeSH
- Teicoplanin pharmacology MeSH
- Vancomycin pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- Bacterial Proteins MeSH
- Lipoglycopeptides MeSH
- Teicoplanin MeSH
- Vancomycin MeSH
Teicoplanin is a natural lipoglycopeptide antibiotic with a similar activity spectrum as vancomycin; however, it has with the added benefit to the patient of low cytotoxicity. Both teicoplanin and vancomycin antibiotics are actively used in medical practice in the prophylaxis and treatment of severe life-threatening infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, Enterococcus faecium and Clostridium difficile. The expression of vancomycin Z (vanZ), encoded either in the vancomycin A (vanA) glycopeptide antibiotic resistance gene cluster or in the genomes of E. faecium, as well as Streptococcus pneumoniae and C. difficile, was shown to specifically compromise the antibiotic efficiency through the inhibition of teicoplanin binding to the bacterial surface. However, the exact mechanisms of this action and protein structure remain unknown. In this study, the three-dimensional structure of VanZ from E. faecium EnGen0191 was predicted by using the I-TASSER web server. Based on the VanZ structure, a benzimidazole based ligand was predicted to bind to the VanZ by molecular docking. Importantly, this new ligand, named G3K, was further confirmed to specifically inhibit VanZ-mediated resistance to teicoplanin in vivo.
See more in PubMed
Mazumdar A., Haddad Y., Milosavljevic V., Michalkova H., Guran R., Bhowmick S., Moulick A. Peptide-carbon quantum dots conjugate, derived from human retinoic acid receptor responder protein 2, against antibiotic-resistant gram positive and gram negative pathogenic bacteria. Nanomaterials. 2020;10:325. doi: 10.3390/nano10020325. PubMed DOI PMC
Mazumdar A., Adam V. Antimicrobial peptides-An alternative candidates to antibiotics against Staphylococcus aureus and its antibiotic-resistant strains. J. Mol. Clin. Med. 2021;4:1–17. doi: 10.31083/j.jmcm.2021.01.208. DOI
Mazumdar A., Haddad Y., Sur V.P., Milosavljevic V., Bhowmick S., Michalkova H., Guran R., Vesely R., Moulick A. Characterization and in vitro analysis of probiotic-derived peptides against multi drug resistance bacterial infections. Front. Microbiol. 2020;11:1963. doi: 10.3389/fmicb.2020.01963. PubMed DOI PMC
Sur V.P., Mazumdar A., Kopel P., Mukherjee S., Vítek P., Michalkova H., Vaculovičová M., Moulick A. A novel ruthenium based coordination compound against pathogenic bacteria. Int. J. Mol. Sci. 2020;21:2656. doi: 10.3390/ijms21072656. PubMed DOI PMC
Sur V.P., Mazumdar A., Ashrafi A., Mukherjee A., Milosavljevic V., Michalkova H., Kopel P., Richtera L., Moulick A. A Novel Biocompatible Titanium–Gadolinium Quantum Dot as a Bacterial Detecting Agent with High Antibacterial Activity. Nanomaterials. 2020;10:778. doi: 10.3390/nano10040778. PubMed DOI PMC
Sur V.P., Kominkova M., Buchtova Z., Dolezelikova K., Zitka O., Moulick A. CdSe QD Biosynthesis in Yeast Using Tryptone-Enriched Media and Their Conjugation with a Peptide Hecate for Bacterial Detection and Killing. Nanomaterials. 2019;9:1463. doi: 10.3390/nano9101463. PubMed DOI PMC
Nikaido H. Multidrug resistance in bacteria. Annu. Rev. Biochem. 2009;78:119–146. doi: 10.1146/annurev.biochem.78.082907.145923. PubMed DOI PMC
Xie O., Slavin M.A., Teh B.W., Bajel A., Douglas A.P., Worth L.J. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting. BMC Infect. Dis. 2020;20:228. doi: 10.1186/s12879-020-04952-5. PubMed DOI PMC
Seol C.A., Park J.S., Sung H., Kim M.-N. Co-colonization of vanA and vanB Enterococcus faecium of clonal complex 17 in a patient with bacteremia due to vanA E. faecium. Diagn. Microbiol. Infect. Dis. 2014;79:141–143. doi: 10.1016/j.diagmicrobio.2014.02.018. PubMed DOI
Jelinkova P., Splichal Z., Jimenez A.M.J., Haddad Y., Mazumdar A., Sur V.P., Milosavljevic V., Kopel P., Buchtelova H., Guran R. Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus. Infect. Drug Resist. 2018;11:1807. doi: 10.2147/IDR.S160975. PubMed DOI PMC
Barna J.C.J., Williams D.H., Stone D.J.M., Leung T.W.C., Doddrell D.M. Structure elucidation of the teicoplanin antibiotics. J. Am. Chem. Soc. 1984;106:4895–4902. doi: 10.1021/ja00329a044. DOI
Coşkun F.A., Mumcuoğlu I., Aksu N., Karahan Z.C., Us E., Tekeli F.A., Baran I., Kanyılmaz D., Kurşun S. Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: The first vanB-positive Enterococcus faecium isolates. Mikrobiyoloji Bul. 2012;46:276–282. PubMed
Arthur M., Depardieu F., Molinas C., Reynolds P., Courvalin P. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene. 1995;154:87–92. doi: 10.1016/0378-1119(94)00851-I. PubMed DOI
Mazumdar A. Ph.D. Thesis. Mendelova univerzita v Brně, Agronomická Fakulta; Brno-sever-Černá Pole, Czech Republic: 2020. Studies on the Effect of Antimicrobial Peptides Conjugated with Nanoparticles on Pathogenic Bacteria.
Lai L., Dai J., Tang H., Zhang S., Wu C., Qiu W., Lu C., Yao H., Fan H., Wu Z. Streptococcus suis serotype 9 strain GZ0565 contains a type VII secretion system putative substrate EsxA that contributes to bacterial virulence and a vanZ-like gene that confers resistance to teicoplanin and dalbavancin in Streptococcus agalactiae. Vet. Microbiol. 2017;205:26–33. doi: 10.1016/j.vetmic.2017.04.030. PubMed DOI
Woods E.C., Wetzel D., Mukerjee M., McBride S.M. Examination of the Clostridioides (Clostridium) difficile VanZ ortholog, CD1240. Anaerobe. 2018;53:108–115. doi: 10.1016/j.anaerobe.2018.06.013. PubMed DOI PMC
Ligozzi M., Lo Cascio G., Fontana R. vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans. Antimicrob. Agents Chemother. 1998;42:2055–2059. doi: 10.1128/AAC.42.8.2055. PubMed DOI PMC
Nygaard M., Kragelund B.B., Papaleo E., Lindorff-Larsen K. An efficient method for estimating the hydrodynamic radius of disordered protein conformations. Biophys. J. 2017;113:550–557. doi: 10.1016/j.bpj.2017.06.042. PubMed DOI PMC
Prakash A., Baer M.D., Mundy C.J., Pfaendtner J. Peptoid backbone flexibility dictates its interaction with water and surfaces: A molecular dynamics investigation. Biomacromolecules. 2018;19:1006–1015. doi: 10.1021/acs.biomac.7b01813. PubMed DOI
Mostofian B., Zhuang T., Cheng X., Nickels J.D. Branched-Chain Fatty Acid Content Modulates Structure, Fluidity, and Phase in Model Microbial Cell Membranes. J. Phys. Chem. B. 2019;123:5814–5821. doi: 10.1021/acs.jpcb.9b04326. PubMed DOI
Sirobhushanam S., Galva C., Sen S., Wilkinson B.J., Gatto C. Broad substrate specificity of phosphotransbutyrylase from Listeria monocytogenes: A potential participant in an alternative pathway for provision of acyl CoA precursors for fatty acid biosynthesis. Biochim Biophys Acta. 2016;1861:1102–1110. doi: 10.1016/j.bbalip.2016.06.003. PubMed DOI PMC
Vimberg V., Zieglerová L., Buriánková K., Branny P., Balíková Novotná G. VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells. Front. Microbiol. 2020;11:566. doi: 10.3389/fmicb.2020.00566. PubMed DOI PMC
Goud N.S., Kumar P., Bharath R.D. Heterocycles-Synthesis and Biological Activities. IntechOpen; London, UK: 2020. Recent Developments of Target-Based Benzimidazole Derivatives as Potential Anticancer Agents. PubMed
Sur V.P. Ph.D. Thesis. Mendelova Univerzita v Brně, Agronomická Fakulta; Brno-sever-Černá Pole, Czech Republic: 2020. Metal Based Coordinate Compounds and Nanoparticles as an Alternative of Antibiotics against Resistant Bacterial Strains.
Nichols D.A., Jaishankar P., Larson W., Smith E., Liu G., Beyrouthy R., Bonnet R., Renslo A.R., Chen Y. Structure-based design of potent and ligand-efficient inhibitors of CTX-M class A β-lactamase. J. Med. Chem. 2012;55:2163–2172. doi: 10.1021/jm2014138. PubMed DOI
de Niederhäusern S., Bondi M., Messi P., Iseppi R., Sabia C., Manicardi G., Anacarso I. Vancomycin-resistance Transferability from VanA Enterococci to Staphylococcus aureus. Curr. Microbiol. 2011;62:1363–1367. doi: 10.1007/s00284-011-9868-6. PubMed DOI
Roy A., Kucukural A., Zhang Y. I-TASSER: A unified platform for automated protein structure and function prediction. Nat. Protoc. 2010;5:725–738. doi: 10.1038/nprot.2010.5. PubMed DOI PMC
Omasits U., Ahrens C.H., Müller S., Wollscheid B. Protter: Interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. 2014;30:884–886. doi: 10.1093/bioinformatics/btt607. PubMed DOI
Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993;26:283–291. doi: 10.1107/S0021889892009944. DOI
Laskowski R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R., Thornton J.M. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 1996;8:477–486. doi: 10.1007/BF00228148. PubMed DOI
Jo S., Kim T., Iyer V.G., Im W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 2008;29:1859–1865. doi: 10.1002/jcc.20945. PubMed DOI
Kumar N., Srivastava R., Prakash A., Lynn A.M. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium Tuberculosis. J. Biomol. Struct. Dyn. 2020;38:3396–3410. doi: 10.1080/07391102.2019.1657499. PubMed DOI
Sur V.P., Sen M.K., Komrskova K. In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease. Molecules. 2021;26:6199. doi: 10.3390/molecules26206199. PubMed DOI PMC